Result of General Meeting

Allergy Therapeutics PLC

31 July 2023

 

Allergy Therapeutics plc

("Allergy Therapeutics", the "Company" or the "Group")

Result of General Meeting

31 July 2023: Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, announces that at the General Meeting today, held for the purposes of approving the Company's annual report and accounts for the year ended 30 June 2022 (the "2022 Accounts"), all resolutions were duly passed.

All resolutions were voted on by way of a poll. The results of the poll were as follows:

Resolution	Votes For	% of votes for	Votes Against	% of votes against	Votes Withheld	Total votes cast
1. To receive the Directors' report, the consolidated financial statements and the auditors' report of the Company for the year ended 30 June 2022 (the "2022 Accounts")	332,831,805	99.75%	822,693	0.25%	97,047	333,751,545
2. To approve the Directors' remuneration report, as set out on pages 64 to 72 of the 2022 Accounts	330,801,478	99.27%	2,443,679	0.73%	506,388	333,751,545

- ENDS -

For further information, please contact:

Allergy Therapeutics

Manuel Llobet, Chief Executive Officer

Martin Hopcroft, Interim Chief Financial Officer

[phone]

Panmure Gordon (Nominated Adviser and Broker)

Freddy Crossley, Emma Earl, Corporate Finance

Rupert Dearden, Corporate Broking

[phone]

Consilium Strategic Communications

Mary-Jane Elliott / David Daley / Davide Salvi

[phone]

[e-mail]

Notes for editors:

About Allergy Therapeutics

Allergy Therapeutics is an international commercial biotechnology company, headquartered in the UK, focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries. Its broad pipeline of products in clinical development includes vaccines for grass, tree, house dust mite and peanut. For more information, please see www.allergytherapeutics.com.

 

END